Global Allergy Diagnostics And Treatment Market

Allergy Diagnostics And Treatment Comprehensive Study by Application (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, Other End Users), Tests Type (Specific IgE testing, Patch testing, Blood testing, Others), Allergy Type (Allergic Rhinitis, Food Allergy, Drug Allergy, Skin Allergy, Insect Allergy, Sinusitis, General Allergy), Medications (Corticosteroids, Leukotrienes inhibitors, Antihistamines, Decongestants, Mast cell inhibitors, Others) Players and Region - Global Market Outlook to 2028

Allergy Diagnostics And Treatment Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Allergy Diagnostics And Treatment Market Scope?
Allergy can be of numerous forms such as asthma, food allergies, rhinitis, conjunctivitis, eczema, urticaria, eosinophilic disorders, drug and insect allergies. The World Allergy Organisation (WAO) assessment of allergy prevalence of the whole population by country ranges between 10 - 40%. Beyond 150 million Europeans suffer from chronic allergic diseases and the current prediction is that by 2025 half of the entire EU population will be affected. The complexity and severity of allergies, especially asthma are on the rise in the young population, who are carrying the largest burden. Rise in the prevalence of allergic diseases and asthma worldwide, especially in developing countries is the main driver for the growth of allergy diagnostics and treatment markets. Urbanization, increase in environmental risk factors such as pollution, smoking, reduced biodiversity are some of the major contributors to the observed upsurge in the prevalence of allergies.

Influencing Trend:
Growing Adoption of Automation for Quicker Turnaround Times and Growth in the Number of Reagent Rental Agreements

Market Growth Drivers:
High Incidence and Large Economic Burden of Allergic Diseases, Rising Environmental Pollution Levels Have Leads to Various Allergies, Increasing Healthcare Expenditure across the Globe and Increasing Access for Allergy Diagnosis Medical Insurance in the United States

Challenges:
Lack of Awareness of Allergic Diseases among the People

Restraints:
Issues Related to the Affordability of Allergy Diagnostics Instruments among Small Laboratories and Physician Clinics

Opportunities:
The Emerging Demand from Asia Pacific Region

The Allergy Diagnostics And Treatment market study is being classified, by Application and major geographies with country level break-up.

Allergy Diagnostics and Treatment market is a fragmented market due to the presence of various players. The players are focusing on developing innovative and new product to improve quality of diagnosis and therapy. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Allergy Diagnostics And Treatment market throughout the predicted period.

Alcon Laboratories, Inc. (Switzerland), BioMerieux, Inc. (France), Danaher Corporation (United States), Hitachi Chemical Diagnostics, Inc. (United States), HOB Biotech Group Co., Ltd (China), Hycor Biomedical, Inc. (United States), Lincoln Diagnostics, Inc. (United States), Omega Diagnostics Plc. (United Kingdom), Siemens Healthcare Diagnostic, Inc. (Germany), Stallergenes Greer, Inc. (United Kingdom) and Thermo Fisher Scientific, Inc. (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Allergy Diagnostics And Treatment market by Type, Application and Region.

On the basis of geography, the market of Allergy Diagnostics And Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In November 2022, Alcon acquired Aerie Pharmaceuticals, Inc. this acquisition helped Alcon to expand its presence in Allergy Diagnostics and Treatment market
In February 2020, Alcon launched Pataday, the Eye Allergy Drop which is approved by the Food and Drug Administration. This launch helped, Alcon to expand its presence in allergy diagnostics and treatment market
On 17 Oct 2019, Stallergenes Greer, a worldwide leader in Allergen Immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development based on Contiguous Overlapping Peptides (COP), announced the start of a new research study to evaluate the effects of second-generation COP allergen immunotherapy in a therapeutic model of birch pollen allergy, with the aim of shortening AIT administration schemes.

Key Target Audience
Allergy Diagnostics & Treatment Test Providers, Allergy Diagnostics & Treatment Medications Manufacturers, Regulatory & Government Bodies, Research Institutes, Research & Consulting Firms, End Users, Downstream Vendors and Others

Allergy Diagnostics And Treatment Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Allergy Diagnostics And Treatment Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Allergy Diagnostics And Treatment industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Diagnostic Laboratories
  • Hospital-Based Laboratories
  • Academic Research Institutes
  • Other End Users
By Tests Type
  • Specific IgE testing
  • Patch testing
  • Blood testing
  • Others

By Allergy Type
  • Allergic Rhinitis
  • Food Allergy
  • Drug Allergy
  • Skin Allergy
  • Insect Allergy
  • Sinusitis
  • General Allergy

By Medications
  • Corticosteroids
  • Leukotrienes inhibitors
  • Antihistamines
  • Decongestants
  • Mast cell inhibitors
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Incidence and Large Economic Burden of Allergic Diseases
      • 3.2.2. Rising Environmental Pollution Levels Have Leads to Various Allergies
      • 3.2.3. Increasing Healthcare Expenditure across the Globe
      • 3.2.4. Increasing Access for Allergy Diagnosis Medical Insurance in the United States
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness of Allergic Diseases among the People
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Automation for Quicker Turnaround Times
      • 3.4.2. Growth in the Number of Reagent Rental Agreements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Allergy Diagnostics And Treatment, by Application, Tests Type, Allergy Type, Medications and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Allergy Diagnostics And Treatment (Value)
      • 5.2.1. Global Allergy Diagnostics And Treatment by: Application (Value)
        • 5.2.1.1. Diagnostic Laboratories
        • 5.2.1.2. Hospital-Based Laboratories
        • 5.2.1.3. Academic Research Institutes
        • 5.2.1.4. Other End Users
      • 5.2.2. Global Allergy Diagnostics And Treatment by: Tests Type (Value)
        • 5.2.2.1. Specific IgE testing
        • 5.2.2.2. Patch testing
        • 5.2.2.3. Blood testing
        • 5.2.2.4. Others
      • 5.2.3. Global Allergy Diagnostics And Treatment by: Allergy Type (Value)
        • 5.2.3.1. Allergic Rhinitis
        • 5.2.3.2. Food Allergy
        • 5.2.3.3. Drug Allergy
        • 5.2.3.4. Skin Allergy
        • 5.2.3.5. Insect Allergy
        • 5.2.3.6. Sinusitis
        • 5.2.3.7. General Allergy
      • 5.2.4. Global Allergy Diagnostics And Treatment by: Medications (Value)
        • 5.2.4.1. Corticosteroids
        • 5.2.4.2. Leukotrienes inhibitors
        • 5.2.4.3. Antihistamines
        • 5.2.4.4. Decongestants
        • 5.2.4.5. Mast cell inhibitors
        • 5.2.4.6. Others
      • 5.2.5. Global Allergy Diagnostics And Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Allergy Diagnostics And Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alcon Laboratories, Inc. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BioMerieux, Inc. (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danaher Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hitachi Chemical Diagnostics, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. HOB Biotech Group Co., Ltd (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hycor Biomedical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lincoln Diagnostics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Omega Diagnostics Plc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Siemens Healthcare Diagnostic, Inc. (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Stallergenes Greer, Inc. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Allergy Diagnostics And Treatment Sale, by Application, Tests Type, Allergy Type, Medications and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Allergy Diagnostics And Treatment (Value)
      • 7.2.1. Global Allergy Diagnostics And Treatment by: Application (Value)
        • 7.2.1.1. Diagnostic Laboratories
        • 7.2.1.2. Hospital-Based Laboratories
        • 7.2.1.3. Academic Research Institutes
        • 7.2.1.4. Other End Users
      • 7.2.2. Global Allergy Diagnostics And Treatment by: Tests Type (Value)
        • 7.2.2.1. Specific IgE testing
        • 7.2.2.2. Patch testing
        • 7.2.2.3. Blood testing
        • 7.2.2.4. Others
      • 7.2.3. Global Allergy Diagnostics And Treatment by: Allergy Type (Value)
        • 7.2.3.1. Allergic Rhinitis
        • 7.2.3.2. Food Allergy
        • 7.2.3.3. Drug Allergy
        • 7.2.3.4. Skin Allergy
        • 7.2.3.5. Insect Allergy
        • 7.2.3.6. Sinusitis
        • 7.2.3.7. General Allergy
      • 7.2.4. Global Allergy Diagnostics And Treatment by: Medications (Value)
        • 7.2.4.1. Corticosteroids
        • 7.2.4.2. Leukotrienes inhibitors
        • 7.2.4.3. Antihistamines
        • 7.2.4.4. Decongestants
        • 7.2.4.5. Mast cell inhibitors
        • 7.2.4.6. Others
      • 7.2.5. Global Allergy Diagnostics And Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Allergy Diagnostics And Treatment: by Application(USD Million)
  • Table 2. Allergy Diagnostics And Treatment Diagnostic Laboratories , by Region USD Million (2017-2022)
  • Table 3. Allergy Diagnostics And Treatment Hospital-Based Laboratories , by Region USD Million (2017-2022)
  • Table 4. Allergy Diagnostics And Treatment Academic Research Institutes , by Region USD Million (2017-2022)
  • Table 5. Allergy Diagnostics And Treatment Other End Users , by Region USD Million (2017-2022)
  • Table 6. Allergy Diagnostics And Treatment: by Tests Type(USD Million)
  • Table 7. Allergy Diagnostics And Treatment Specific IgE testing , by Region USD Million (2017-2022)
  • Table 8. Allergy Diagnostics And Treatment Patch testing , by Region USD Million (2017-2022)
  • Table 9. Allergy Diagnostics And Treatment Blood testing , by Region USD Million (2017-2022)
  • Table 10. Allergy Diagnostics And Treatment Others , by Region USD Million (2017-2022)
  • Table 11. Allergy Diagnostics And Treatment: by Allergy Type(USD Million)
  • Table 12. Allergy Diagnostics And Treatment Allergic Rhinitis , by Region USD Million (2017-2022)
  • Table 13. Allergy Diagnostics And Treatment Food Allergy , by Region USD Million (2017-2022)
  • Table 14. Allergy Diagnostics And Treatment Drug Allergy , by Region USD Million (2017-2022)
  • Table 15. Allergy Diagnostics And Treatment Skin Allergy , by Region USD Million (2017-2022)
  • Table 16. Allergy Diagnostics And Treatment Insect Allergy , by Region USD Million (2017-2022)
  • Table 17. Allergy Diagnostics And Treatment Sinusitis , by Region USD Million (2017-2022)
  • Table 18. Allergy Diagnostics And Treatment General Allergy , by Region USD Million (2017-2022)
  • Table 19. Allergy Diagnostics And Treatment: by Medications(USD Million)
  • Table 20. Allergy Diagnostics And Treatment Corticosteroids , by Region USD Million (2017-2022)
  • Table 21. Allergy Diagnostics And Treatment Leukotrienes inhibitors , by Region USD Million (2017-2022)
  • Table 22. Allergy Diagnostics And Treatment Antihistamines , by Region USD Million (2017-2022)
  • Table 23. Allergy Diagnostics And Treatment Decongestants , by Region USD Million (2017-2022)
  • Table 24. Allergy Diagnostics And Treatment Mast cell inhibitors , by Region USD Million (2017-2022)
  • Table 25. Allergy Diagnostics And Treatment Others , by Region USD Million (2017-2022)
  • Table 26. South America Allergy Diagnostics And Treatment, by Country USD Million (2017-2022)
  • Table 27. South America Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 28. South America Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 29. South America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 30. South America Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 31. Brazil Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 32. Brazil Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 33. Brazil Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 34. Brazil Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 35. Argentina Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 36. Argentina Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 37. Argentina Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 38. Argentina Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 39. Rest of South America Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 40. Rest of South America Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 41. Rest of South America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 42. Rest of South America Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 43. Asia Pacific Allergy Diagnostics And Treatment, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 45. Asia Pacific Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 46. Asia Pacific Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 47. Asia Pacific Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 48. China Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 49. China Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 50. China Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 51. China Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 52. Japan Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 53. Japan Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 54. Japan Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 55. Japan Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 56. India Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 57. India Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 58. India Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 59. India Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 60. South Korea Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 61. South Korea Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 62. South Korea Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 63. South Korea Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 64. Taiwan Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 65. Taiwan Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 66. Taiwan Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 67. Taiwan Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 68. Australia Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 69. Australia Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 70. Australia Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 71. Australia Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 76. Europe Allergy Diagnostics And Treatment, by Country USD Million (2017-2022)
  • Table 77. Europe Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 78. Europe Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 79. Europe Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 80. Europe Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 81. Germany Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 82. Germany Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 83. Germany Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 84. Germany Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 85. France Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 86. France Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 87. France Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 88. France Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 89. Italy Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 90. Italy Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 91. Italy Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 92. Italy Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 93. United Kingdom Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 94. United Kingdom Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 95. United Kingdom Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 96. United Kingdom Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 97. Netherlands Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 98. Netherlands Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 99. Netherlands Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 100. Netherlands Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 101. Rest of Europe Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 102. Rest of Europe Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 103. Rest of Europe Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 104. Rest of Europe Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 105. MEA Allergy Diagnostics And Treatment, by Country USD Million (2017-2022)
  • Table 106. MEA Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 107. MEA Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 108. MEA Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 109. MEA Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 110. Middle East Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 111. Middle East Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 112. Middle East Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 113. Middle East Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 114. Africa Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 115. Africa Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 116. Africa Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 117. Africa Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 118. North America Allergy Diagnostics And Treatment, by Country USD Million (2017-2022)
  • Table 119. North America Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 120. North America Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 121. North America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 122. North America Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 123. United States Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 124. United States Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 125. United States Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 126. United States Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 127. Canada Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 128. Canada Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 129. Canada Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 130. Canada Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 131. Mexico Allergy Diagnostics And Treatment, by Application USD Million (2017-2022)
  • Table 132. Mexico Allergy Diagnostics And Treatment, by Tests Type USD Million (2017-2022)
  • Table 133. Mexico Allergy Diagnostics And Treatment, by Allergy Type USD Million (2017-2022)
  • Table 134. Mexico Allergy Diagnostics And Treatment, by Medications USD Million (2017-2022)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Allergy Diagnostics And Treatment: by Application(USD Million)
  • Table 147. Allergy Diagnostics And Treatment Diagnostic Laboratories , by Region USD Million (2023-2028)
  • Table 148. Allergy Diagnostics And Treatment Hospital-Based Laboratories , by Region USD Million (2023-2028)
  • Table 149. Allergy Diagnostics And Treatment Academic Research Institutes , by Region USD Million (2023-2028)
  • Table 150. Allergy Diagnostics And Treatment Other End Users , by Region USD Million (2023-2028)
  • Table 151. Allergy Diagnostics And Treatment: by Tests Type(USD Million)
  • Table 152. Allergy Diagnostics And Treatment Specific IgE testing , by Region USD Million (2023-2028)
  • Table 153. Allergy Diagnostics And Treatment Patch testing , by Region USD Million (2023-2028)
  • Table 154. Allergy Diagnostics And Treatment Blood testing , by Region USD Million (2023-2028)
  • Table 155. Allergy Diagnostics And Treatment Others , by Region USD Million (2023-2028)
  • Table 156. Allergy Diagnostics And Treatment: by Allergy Type(USD Million)
  • Table 157. Allergy Diagnostics And Treatment Allergic Rhinitis , by Region USD Million (2023-2028)
  • Table 158. Allergy Diagnostics And Treatment Food Allergy , by Region USD Million (2023-2028)
  • Table 159. Allergy Diagnostics And Treatment Drug Allergy , by Region USD Million (2023-2028)
  • Table 160. Allergy Diagnostics And Treatment Skin Allergy , by Region USD Million (2023-2028)
  • Table 161. Allergy Diagnostics And Treatment Insect Allergy , by Region USD Million (2023-2028)
  • Table 162. Allergy Diagnostics And Treatment Sinusitis , by Region USD Million (2023-2028)
  • Table 163. Allergy Diagnostics And Treatment General Allergy , by Region USD Million (2023-2028)
  • Table 164. Allergy Diagnostics And Treatment: by Medications(USD Million)
  • Table 165. Allergy Diagnostics And Treatment Corticosteroids , by Region USD Million (2023-2028)
  • Table 166. Allergy Diagnostics And Treatment Leukotrienes inhibitors , by Region USD Million (2023-2028)
  • Table 167. Allergy Diagnostics And Treatment Antihistamines , by Region USD Million (2023-2028)
  • Table 168. Allergy Diagnostics And Treatment Decongestants , by Region USD Million (2023-2028)
  • Table 169. Allergy Diagnostics And Treatment Mast cell inhibitors , by Region USD Million (2023-2028)
  • Table 170. Allergy Diagnostics And Treatment Others , by Region USD Million (2023-2028)
  • Table 171. South America Allergy Diagnostics And Treatment, by Country USD Million (2023-2028)
  • Table 172. South America Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 173. South America Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 174. South America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 175. South America Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 176. Brazil Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 177. Brazil Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 178. Brazil Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 179. Brazil Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 180. Argentina Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 181. Argentina Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 182. Argentina Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 183. Argentina Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 184. Rest of South America Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 185. Rest of South America Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 186. Rest of South America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 187. Rest of South America Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 188. Asia Pacific Allergy Diagnostics And Treatment, by Country USD Million (2023-2028)
  • Table 189. Asia Pacific Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 190. Asia Pacific Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 191. Asia Pacific Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 192. Asia Pacific Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 193. China Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 194. China Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 195. China Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 196. China Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 197. Japan Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 198. Japan Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 199. Japan Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 200. Japan Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 201. India Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 202. India Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 203. India Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 204. India Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 205. South Korea Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 206. South Korea Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 207. South Korea Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 208. South Korea Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 209. Taiwan Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 210. Taiwan Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 211. Taiwan Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 212. Taiwan Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 213. Australia Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 214. Australia Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 215. Australia Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 216. Australia Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 217. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 218. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 219. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 220. Rest of Asia-Pacific Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 221. Europe Allergy Diagnostics And Treatment, by Country USD Million (2023-2028)
  • Table 222. Europe Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 223. Europe Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 224. Europe Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 225. Europe Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 226. Germany Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 227. Germany Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 228. Germany Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 229. Germany Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 230. France Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 231. France Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 232. France Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 233. France Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 234. Italy Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 235. Italy Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 236. Italy Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 237. Italy Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 238. United Kingdom Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 239. United Kingdom Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 240. United Kingdom Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 241. United Kingdom Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 242. Netherlands Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 243. Netherlands Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 244. Netherlands Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 245. Netherlands Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 246. Rest of Europe Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 247. Rest of Europe Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 248. Rest of Europe Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 249. Rest of Europe Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 250. MEA Allergy Diagnostics And Treatment, by Country USD Million (2023-2028)
  • Table 251. MEA Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 252. MEA Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 253. MEA Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 254. MEA Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 255. Middle East Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 256. Middle East Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 257. Middle East Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 258. Middle East Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 259. Africa Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 260. Africa Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 261. Africa Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 262. Africa Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 263. North America Allergy Diagnostics And Treatment, by Country USD Million (2023-2028)
  • Table 264. North America Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 265. North America Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 266. North America Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 267. North America Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 268. United States Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 269. United States Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 270. United States Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 271. United States Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 272. Canada Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 273. Canada Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 274. Canada Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 275. Canada Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 276. Mexico Allergy Diagnostics And Treatment, by Application USD Million (2023-2028)
  • Table 277. Mexico Allergy Diagnostics And Treatment, by Tests Type USD Million (2023-2028)
  • Table 278. Mexico Allergy Diagnostics And Treatment, by Allergy Type USD Million (2023-2028)
  • Table 279. Mexico Allergy Diagnostics And Treatment, by Medications USD Million (2023-2028)
  • Table 280. Research Programs/Design for This Report
  • Table 281. Key Data Information from Secondary Sources
  • Table 282. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Allergy Diagnostics And Treatment: by Application USD Million (2017-2022)
  • Figure 5. Global Allergy Diagnostics And Treatment: by Tests Type USD Million (2017-2022)
  • Figure 6. Global Allergy Diagnostics And Treatment: by Allergy Type USD Million (2017-2022)
  • Figure 7. Global Allergy Diagnostics And Treatment: by Medications USD Million (2017-2022)
  • Figure 8. South America Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 9. Asia Pacific Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 10. Europe Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 11. MEA Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 12. North America Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 13. Global Allergy Diagnostics And Treatment share by Players 2022 (%)
  • Figure 14. Global Allergy Diagnostics And Treatment share by Players (Top 3) 2022(%)
  • Figure 15. Global Allergy Diagnostics And Treatment share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Alcon Laboratories, Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Alcon Laboratories, Inc. (Switzerland) Revenue: by Geography 2022
  • Figure 19. BioMerieux, Inc. (France) Revenue, Net Income and Gross profit
  • Figure 20. BioMerieux, Inc. (France) Revenue: by Geography 2022
  • Figure 21. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 23. Hitachi Chemical Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Hitachi Chemical Diagnostics, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. HOB Biotech Group Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 26. HOB Biotech Group Co., Ltd (China) Revenue: by Geography 2022
  • Figure 27. Hycor Biomedical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Hycor Biomedical, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Lincoln Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Lincoln Diagnostics, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Omega Diagnostics Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Omega Diagnostics Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Siemens Healthcare Diagnostic, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Siemens Healthcare Diagnostic, Inc. (Germany) Revenue: by Geography 2022
  • Figure 35. Stallergenes Greer, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Stallergenes Greer, Inc. (United Kingdom) Revenue: by Geography 2022
  • Figure 37. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 39. Global Allergy Diagnostics And Treatment: by Application USD Million (2023-2028)
  • Figure 40. Global Allergy Diagnostics And Treatment: by Tests Type USD Million (2023-2028)
  • Figure 41. Global Allergy Diagnostics And Treatment: by Allergy Type USD Million (2023-2028)
  • Figure 42. Global Allergy Diagnostics And Treatment: by Medications USD Million (2023-2028)
  • Figure 43. South America Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 44. Asia Pacific Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 45. Europe Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 46. MEA Allergy Diagnostics And Treatment Share (%), by Country
  • Figure 47. North America Allergy Diagnostics And Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alcon Laboratories, Inc. (Switzerland)
  • BioMerieux, Inc. (France)
  • Danaher Corporation (United States)
  • Hitachi Chemical Diagnostics, Inc. (United States)
  • HOB Biotech Group Co., Ltd (China)
  • Hycor Biomedical, Inc. (United States)
  • Lincoln Diagnostics, Inc. (United States)
  • Omega Diagnostics Plc. (United Kingdom)
  • Siemens Healthcare Diagnostic, Inc. (Germany)
  • Stallergenes Greer, Inc. (United Kingdom)
  • Thermo Fisher Scientific, Inc. (United States)
Select User Access Type

Key Highlights of Report


Nov 2023 221 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Allergy Diagnostics And Treatment Market Quantitative research analysis
Global Allergy Diagnostics And Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Allergy Diagnostics And Treatment market are Alcon Laboratories, Inc. (Switzerland), BioMerieux, Inc. (France), Danaher Corporation (United States), Hitachi Chemical Diagnostics, Inc. (United States), HOB Biotech Group Co., Ltd (China), Hycor Biomedical, Inc. (United States), Lincoln Diagnostics, Inc. (United States), Omega Diagnostics Plc. (United Kingdom), Siemens Healthcare Diagnostic, Inc. (Germany), Stallergenes Greer, Inc. (United Kingdom) and Thermo Fisher Scientific, Inc. (United States).
In this highly competitive & fast evolving Allergy Diagnostics And Treatment industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users are the potential customers of Allergy Diagnostics And Treatment industry.

Know More About Global Allergy Diagnostics And Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Monoclonal Antibodies Drug Comprehensive Study by Application (Oncology, Autoimmune, Inflammatory Diseases, Respiratory Diseases, Ophthalmology, Others), Origin (Murine Antibodies, Human Antibodies, ...
$ 3650
Medical Skincare Comprehensive Study by Type (Cleansers, Toners, Scrubs & Masks, Serums, Moisturizers, Eye Creams, SPF, Others), Application (Acne, Anti-Aging, Brightening, Sensitive Skin, Dry Skin, ...
$ 3750
Weight Loss Therapeutics Comprehensive Study by Therapy (Intensive Behavioural Therapy, Self-Monitoring Therapy), End Users (Hospitals, Therapy Clinics, Pharmaceuticals Organization), Distribution Ch...
$ 3650
Genitourinary System Treatment Comprehensive Study by Type (OTC, Rx Drugs), Application (Hospital, Clinics, Ambulatory Surgical Centers), Drugs (Hormonal Therapy, Impotence Agents, Uterine Relaxants,...
$ 3750
Biliary Tumor Comprehensive Study by Type (Mecine, Surgery, Other), Application (Hospitals, Clinics, Other) Players and Region - Global Market Outlook to 2029
$ 3500
Neutropenia Treatment Comprehensive Study by Type (Granulocyte -colony-stimulating factor (G-CSF), Antibiotics, Antifungal drugs), Disease Type (Cyclic neutropenia, Kostmann’s syndrome, Chronic idiop...
$ 3750